Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Ocugen Inc.

Start price
Target price
Perf. (%)
€6.88
23.02.21
-
23.02.22
34.59%
01.03.21

Could be worthwhile Investment >10% per year
thyssenkrupp AG ADR

Start price
Target price
Perf. (%)
€6.15
05.12.20
-
05.12.21
85.37%
27.02.21

Top 10 in its market
Probably not worthwhile Investment
Significant cyclical dependencies
Business model of the past or high risk
buy
Niu Technologies

Start price
Target price
Perf. (%)
€35.50
19.02.21
€38.00
-13.52%
23.02.21

Risky Investment
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€8.90
18.02.21
€12.00
16.05.21
-22.70%
23.02.21

Could be worthwhile Investment >10% per year
Nikola Corp.

Start price
Target price
Perf. (%)
€19.85
08.02.21
-
08.02.22
-9.17%
22.02.21

Risky Investment
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.02
17.02.21
€12.00
16.05.21
-1.33%
18.02.21

Could be worthwhile Investment >10% per year
buy
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.40
16.02.21
€12.00
16.05.21
-4.04%
17.02.21

Could be worthwhile Investment >10% per year
Everfuel A/S

Start price
Target price
Perf. (%)
€6.20
28.11.20
-
28.11.21
83.06%
16.02.21

Business model of the past or high risk
Below average Marketposition
Risky Investment
Significant cyclical dependencies
Ocugen Inc.

Start price
Target price
Perf. (%)
€9.78
16.02.21
€5.00
16.05.21
-3.89%
16.02.21

Could be worthwhile Investment >10% per year
buy
Futu Holdings Ltd.

Start price
Target price
Perf. (%)
€36.20
13.11.20
€109.00
13.05.21
234.25%
12.02.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
Higher risks for its business
Ocugen Inc.

Start price
Target price
Perf. (%)
€11.35
08.02.21
€8.00
08.02.22
-30.04%
11.02.21

Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Xpel Inc.

Start price
Target price
Perf. (%)
€44.00
25.01.21
-
25.01.22
7.27%
09.02.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
buy
Synlogic Inc.

Start price
Target price
Perf. (%)
€3.00
14.12.20
€3.00
14.12.21
0.00%
29.01.21

Known brand
Could be worthwhile Investment >10% per year
Good culture
Business model of the past or high risk
buy
Biocardia Inc.

Start price
Target price
Perf. (%)
€4.53
14.12.20
€5.00
14.12.21
-24.50%
29.01.21

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.20
14.12.20
€11.00
14.12.21
15.85%
29.01.21

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
buy
Aileron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.50
11.01.21
-
11.01.22
-6.67%
29.01.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Growths slower than the competition
Sunworks Inc.

Start price
Target price
Perf. (%)
€24.00
25.01.21
€15.00
25.01.22
-39.58%
28.01.21

Capable Management
Probably not worthwhile Investment
Little innovation
buy
Navya S.a.

Start price
Target price
Perf. (%)
€4.50
26.11.20
€5.00
-29.33%
26.01.21

Risky Investment
buy
Xpel Inc.

Start price
Target price
Perf. (%)
€16.80
08.08.20
-
04.11.21
161.90%
25.01.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Nikola Corp.

Start price
Target price
Perf. (%)
€22.10
18.11.20
-
18.11.21
-23.53%
24.01.21

Innovative
Future proof or reliable business model
Risky Investment
Higher risks for its business
buy
Sunworks Inc.

Start price
Target price
Perf. (%)
€6.30
11.01.21
€17.00
11.01.22
139.68%
22.01.21

Revenue growth >5% per year expected
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Vonovia SE ADR

Start price
Target price
Perf. (%)
€26.59
28.10.20
-
04.11.21
7.00%
05.01.21

Small cyclical dependencies
Market Leader or Top 3
Higher risks for its business
Rainforest Resources Inc.

Start price
Target price
Perf. (%)
€1.61
28.12.20
€1.00
-6.21%
29.12.20

Risky Investment
Business model of the past or high risk
Little known brand
Alfen

Start price
Target price
Perf. (%)
€69.40
17.12.20
€60.00
-2.74%
21.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
buy
Alfen

Start price
Target price
Perf. (%)
€76.00
24.11.20
€80.00
-8.68%
17.12.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year